共 98 条
[1]
Parkin DM(2005)Global cancer statistics,2002 CA Cancer J Clin 55 74-108
[2]
Bray F(1995)Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials Br Med J 311 899-909
[3]
Ferlay J(2005)Paclitaxel and gemcitabine vs. carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC) ASCO Meeting Abstracts 23 7000-153
[4]
Kosmidis PA(2005)Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group J Clin Oncol 23 142-8388
[5]
Kalofonos C(2005)Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: The Swedish Lung Cancer Study Group J Clin Oncol 23 8380-1826
[6]
Syrigos K(1994)Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study J Clin Oncol 12 1821-1540
[7]
Rudd RM(1994)Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study J Clin Oncol 12 1535-5937
[8]
Gower NH(2005)Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer J Clin Oncol 23 5929-118
[9]
Spiro SG(2005)Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells Mol Pharmacol 68 110-2943
[10]
Sederholm C(2004)Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines Clin Cancer Res 10 2936-3493